Location out of bounds


All Investigators
Lisa Baumann Kreuziger, MD, MS

Lisa Baumann Kreuziger, MD, MS

Associate Medical Director, Hematology
Associate Investigator

Associate Investigator
Versiti Blood Research Institute

Assistant Professor of Medicine
Medical College of Wisconsin

Contact Us

Lisa Baumann Kreuziger, MD, MS

Associate Medical Director, Hematology
Associate Investigator
Email (414) 937-6826 Fax: (414) 937-6580

  • Research Interests

    Dr. Baumann Kreuziger specializes in non-malignant hematology with an emphasis on patients with clotting and bleeding disorders.  Dr. Baumann Kreuziger is interested in the underlying mechanisms of thrombosis and optimal treatment strategies for patients with thrombosis. 

  • Grant Support
    • CTSI of Southern Wisconsin Pilot Grant
  • Lab

    Blood Center of Wisconsin Research Staff:

    Research Coordinator:
    Zora Jovanovic, RN

  • Publications
    • Baumann Kreuziger LM, Massicotte MP. Mechanical circulatory support: balancing bleeding and clotting in high-risk patients. Hematology Am Soc Hematol Educ Program. 2015 Dec 5;2015(1):61-8. PMID: 26637702
    • Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ. Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States. Transfus Apher Sci. 2016 Feb;54(1):158-62. PMID 26775259
    • Wood JP, Baumann Kreuziger LM, Desai UR, Mast AE: Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins. Br J Haematol. 2016 Oct;175(1):123-32. PMID: 27301751
    • Dang G, Epperla N, Muppidi V, Sahr N, Pan A, Simpson P, Baumann Kreuziger, LM. Medical Management of Pump Thrombosis in Patients with Continuous Flow Left Ventricular Assist Devices: Systematic Review & Meta-analysis. ASAIO Journal, 2016 Dec 13 (Epub). PMID: 27984314
    • Wood JP, Baumann Kreuziger LM, Ellery PE, Maroney SA, Mast AE. Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state. Blood Advances, 2017 Feb 14;1(6):386-39.
    • Use of romiplostim for refractory primary immune thrombocytopenia during pregnancy.  Samuelson BT, Baumann Kreuziger L, Gernsheimer T. Clinical Obstetrics, Gynecology and Reproductive Medicine.  2017 Jan 12: Epub only.
    • Bhandari S, Mohammed Abdul MK, Dhakal B, Kreuziger LB, Saeian K, Stein D. Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection. Inflamm Bowel Dis. 2017 Aug 22. PMID: 28837518.
    • Epperla N, Hemauer K, Hamadani M, Friedman KD, Kreuziger LB. Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy. Transfusion. 2017 Aug 23.  PMID:28836275.
    • Baumann Kreuziger LM, Slaughter MS, Sundareswaran K, Mast AE. Clinical Relevance of Histopathologic analysis of HeartMate II thrombi, ASAIO Journal, accepted.

This website uses cookies to ensure you get the best experience on our website. Learn more